FDA’s Gottlieb makes strong push to fight opioid crisis with medication-assisted treatment
The FDA head announced new steps the agency would take to promote the use and development of medication-assisted treatment for substance use disorder.
WASHINGTON — Scott Gottlieb, commissioner of the Food and Drug Administration, announced new steps the agency would take to promote the use and development of medication-assisted treatment for substance use disorder at a House hearing on Wednesday.
Gottlieb also rapped the for what he called “often inadequate” coverage of existing therapies that combine counseling and medication-assisted treatment.
